Russian Chemical Reviews · 2020 · 17 citations · 86 references
Human BodyMedicineSmall Molecule CompoundsCovid-19 PandemicViral PathogenesisImmunologyAntiviral TherapyVirologySmall Molecule MedicationsCovid-19 EpidemiologyCovid-19 PathogenesisViral Structural ProteinPharmacologyAntiviral CompoundAntiviral DrugSmall MoleculesCovid-19
The review summarizes the publications, available at the time it was written, addressing the chemical and biological processes that occur in the human body upon exposure to coronaviruses, in particular SARS-CoV-2. The mechanisms of viral particle entry into the cell, viral replication and impact on the immune system and on oxygen transport system are considered. The causes behind complications of the viral infection, such as vasculitis, thrombosis, cytokine storm and lung fibrosis, are discussed. The latest research in the field of small molecule medications to counteract the virus is surveyed. Molecular targets and possible vectors to exploit them are considered. The review is primarily written for specialists who want to understand the chains of activation, replication, action and inhibition of SARS-CoV-2. Due to the short period of such studies, the data on complexes of small molecule compounds with possible protein targets are not numerous, but they will be useful in the search and synthesis of new potentially effective drugs. The bibliography includes 144 references.
86
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.3K citations · Full text
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · Nature · 2020 · 23.1K citations · Full text
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Qun Li, Xuhua Guan, Peng Wu et al. · New England Journal of Medicine · 2020 · 17.8K citations · Full text